|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
28,231,000 |
Market
Cap: |
69.17(M) |
Last
Volume: |
11,787 |
Avg
Vol: |
5,418 |
52
Week Range: |
$2.45 - $2.45 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Acuta Capital Fund, Lp |
10% Owner |
|
2017-01-27 |
4 |
B |
$1.51 |
$3,993 |
D/D |
2,640 |
2,833,000 |
2.37 |
- |
|
Deerfield Special Situations Fund, L.p. |
Possible Member of 10% Group |
|
2017-01-26 |
4 |
S |
$1.46 |
$752,941 |
I/I |
(517,450) |
2,358,636 |
|
- |
|
Deerfield Special Situations Fund, L.p. |
Possible Member of 10% Group |
|
2017-01-25 |
4 |
S |
$1.50 |
$107,223 |
I/I |
(71,468) |
2,876,086 |
|
- |
|
Deerfield Special Situations Fund, L.p. |
Possible Member of 10% Group |
|
2017-01-24 |
4 |
S |
$1.50 |
$71,065 |
I/I |
(47,320) |
2,947,554 |
|
- |
|
Deerfield Special Situations Fund, L.p. |
Possible Member of 10% Group |
|
2017-01-23 |
4 |
S |
$1.47 |
$127,002 |
I/I |
(86,691) |
2,994,874 |
|
- |
|
Acuta Capital Fund, Lp |
10% Owner |
|
2017-01-20 |
4 |
B |
$1.55 |
$8,782 |
D/D |
5,676 |
2,830,360 |
2.37 |
- |
|
Deerfield Special Situations Fund, L.p. |
Possible Member of 10% Group |
|
2017-01-20 |
4 |
S |
$1.53 |
$71,267 |
I/I |
(46,522) |
3,081,565 |
|
- |
|
Acuta Capital Fund, Lp |
10% Owner |
|
2017-01-19 |
4 |
B |
$1.60 |
$62,296 |
D/D |
38,940 |
2,824,684 |
2.45 |
- |
|
Deerfield Special Situations Fund, L.p. |
Possible Member of 10% Group |
|
2017-01-19 |
4 |
S |
$1.60 |
$115,082 |
I/I |
(71,913) |
3,128,087 |
|
- |
|
Acuta Capital Fund, Lp |
10% Owner |
|
2017-01-18 |
4 |
B |
$1.69 |
$18,262 |
D/D |
10,829 |
2,785,744 |
2.37 |
- |
|
Acuta Capital Fund, Lp |
10% Owner |
|
2017-01-17 |
4 |
B |
$1.72 |
$1,744 |
D/D |
1,015 |
2,774,915 |
2.37 |
- |
|
Acuta Capital Fund, Lp |
10% Owner |
|
2017-01-13 |
4 |
B |
$1.72 |
$5,437 |
D/D |
3,170 |
2,773,900 |
2.37 |
- |
|
Acuta Capital Fund, Lp |
10% Owner |
|
2017-01-11 |
4 |
B |
$1.65 |
$13,417 |
D/D |
8,118 |
2,770,730 |
2.37 |
- |
|
Acuta Capital Fund, Lp |
10% Owner |
|
2017-01-10 |
4 |
B |
$1.61 |
$5,426 |
D/D |
3,360 |
2,762,612 |
2.37 |
- |
|
Acuta Capital Fund, Lp |
10% Owner |
|
2017-01-09 |
4 |
B |
$1.63 |
$5,494 |
D/D |
3,366 |
2,759,252 |
2.37 |
- |
|
Weisshaar Kenneth R |
Director |
|
2017-01-09 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
40,303 |
|
- |
|
Thomas James E |
Director |
|
2017-01-09 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
33,454 |
|
- |
|
Benni Paul |
Chief Scientific Officer |
|
2017-01-09 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
116,071 |
|
- |
|
Gamelin John |
Vice President, R&D |
|
2017-01-09 |
4 |
A |
$0.00 |
$0 |
D/D |
45,000 |
105,000 |
|
- |
|
Patton Thomas M |
President & CEO |
|
2017-01-09 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
841,677 |
|
- |
|
Baird Jeffery A |
Chief Financial Officer |
|
2017-01-09 |
4 |
A |
$0.00 |
$0 |
D/D |
45,000 |
180,789 |
|
- |
|
Molloy Paul A |
Director |
|
2017-01-09 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
12,500 |
|
- |
|
Rainey Gregory P |
Director |
|
2017-01-09 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
40,431 |
|
- |
|
Milinazzo Alan |
Director |
|
2017-01-09 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
12,500 |
|
- |
|
Tune Kathleen A |
Director |
|
2017-01-09 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
33,454 |
|
- |
|
200 Records found
|
|
Page 7 of 8 |
|
|